Earnings · China A-shares

Shandong Sinobioway Biomedicine Co.,Ltd. Class A (002581) earnings

Shandong Sinobioway Biomedicine Co.,Ltd. Class A published its Q3 report on 2026-10-22: net profit -98.57% year on year, -59.65% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -3.14% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-22
Period end
2026-09-30
Net profit YoY
-98.57%
Excl. one-offs YoY
-59.65%
Result
Bad / loss
Quality score
59
Quality
Questionable
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-1.67%—
3 days-3.14%—
7 days-14.23%—
14 days-14.64%—

Report history

Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 3 of 7 reports (average -3.88%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-23-¥136.64M-98.57%-59.65%+45.97%-0.21-7.61%-3.14%——
2026 interim report2026-08-28-¥95.47M-41.85%-40.06%+32.87%-0.14-5.28%+0.97%-6.77%+2.92%
2026 Q1 report2026-04-29-¥54.23M-47.15%-47.43%+24.15%-0.08-2.97%-14.35%-49.93%-50.88%
2025 annual report2026-04-29-¥116.28M+15.32%-17.49%-23.75%-0.18-6.18%-14.35%-49.93%-50.88%
2025 Q3 report2025-10-29-¥68.81M-570.46%—-57.73%-0.10-3.62%+5.11%+0.67%+4.14%
2025 interim report2025-08-20-¥67.30M-127.26%—-66.42%-0.10-3.55%-1.69%+3.64%-6.41%
2025 Q1 report2025-04-29-¥36.85M-33.01%-31.93%-57.84%-0.06-1.93%+6.89%+42.66%+40.08%
2024 annual report2025-04-24-¥137.31M+58.70%+65.02%-16.14%-0.21-6.87%-20.95%+6.39%+4.12%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 002581

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.